Neuberger Berman Group LLC Astrazeneca PLC Transaction History
Neuberger Berman Group LLC
- $130 Billion
- Q3 2025
A detailed history of Neuberger Berman Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 5,067,533 shares of AZN stock, worth $453 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
5,067,533
Previous 4,994,198
1.47%
Holding current value
$453 Million
Previous $349 Million
11.4%
% of portfolio
0.3%
Previous 0.28%
Shares
36 transactions
Others Institutions Holding AZN
# of Institutions
1,517Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...